Biomaterial Database

Carbapenem-resistant Acinetobacter baumannii bacteremia in neonates. 2013

Narongsak Nakwan, and Kulkanya Chokephaibulkit

UI	MeSH Term	Description	Entries
D008297	Male		Males
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000151	Acinetobacter Infections	Infections with bacteria of the genus ACINETOBACTER.	Mimae Infections,Infections, Acinetobacter,Infections, Mimae,Acinetobacter Infection,Infection, Acinetobacter,Infection, Mimae,Mimae Infection
D000900	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA.	Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016470	Bacteremia	The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.	Bacteremias
D040981	Acinetobacter baumannii	A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics.	Bacterium anitratum

Related Publications

Narongsak Nakwan, and Kulkanya Chokephaibulkit

Carbapenem-resistant Acinetobacter baumannii Bacteremia in Liver Transplant Recipients.

May 2018, Transplantation proceedings,

Narongsak Nakwan, and Kulkanya Chokephaibulkit

Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.

June 2015, Expert review of anti-infective therapy,

Narongsak Nakwan, and Kulkanya Chokephaibulkit

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis.

July 2013, BMC infectious diseases,

Narongsak Nakwan, and Kulkanya Chokephaibulkit

Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia.

November 2014, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,

Narongsak Nakwan, and Kulkanya Chokephaibulkit

Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.

December 2010, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

Narongsak Nakwan, and Kulkanya Chokephaibulkit

[Carbapenem-resistant Acinetobacter baumannii strains].

January 2010, Medycyna doswiadczalna i mikrobiologia,

Narongsak Nakwan, and Kulkanya Chokephaibulkit

Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.

December 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,

Narongsak Nakwan, and Kulkanya Chokephaibulkit

Treating carbapenem-resistant Acinetobacter baumannii infections.

September 2023, The Lancet. Infectious diseases,

Narongsak Nakwan, and Kulkanya Chokephaibulkit

Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.

October 2012, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,